Welcome to LookChem.com Sign In|Join Free

CAS

  • or

883106-52-3

Post Buying Request

883106-52-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • [1-(4-Aminobenzenesulfonyl)piperidin-4-yl]carbamic acid tert-butyl ester

    Cas No: 883106-52-3

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier

883106-52-3 Usage

Description

[1-(4-AMINO-BENZENESULFONYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER, with the molecular formula C19H28N4O4S, is a piperidine derivative featuring a carbamic acid ester group. [1-(4-AMINO-BENZENESULFONYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER is recognized for its unique chemical structure and pharmacological properties, which contribute to its potential as a building block in drug discovery and development. The presence of the tert-butyl ester group in the molecule enhances its stability and reactivity in various chemical reactions.

Uses

Used in Pharmaceutical Synthesis:
[1-(4-AMINO-BENZENESULFONYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique chemical structure allows it to be a valuable component in the development of new medications, potentially leading to the creation of novel therapeutics.
Used in Agrochemical Development:
In the agrochemical industry, [1-(4-AMINO-BENZENESULFONYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER is utilized as a key compound in the development of pesticides and other agricultural chemicals. Its incorporation into these products can enhance their effectiveness and selectivity, contributing to more efficient and targeted pest control solutions.
Used in Chemical Research:
[1-(4-AMINO-BENZENESULFONYL)-PIPERIDIN-4-YL]-CARBAMIC ACID TERT-BUTYL ESTER serves as a valuable research tool in the field of chemistry. Its unique properties make it an attractive candidate for studying various chemical reactions and mechanisms, potentially leading to advancements in synthetic methods and a deeper understanding of chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 883106-52-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,3,1,0 and 6 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 883106-52:
(8*8)+(7*8)+(6*3)+(5*1)+(4*0)+(3*6)+(2*5)+(1*2)=173
173 % 10 = 3
So 883106-52-3 is a valid CAS Registry Number.

883106-52-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl {1-[(4-aminophenyl)sulfonyl]-4-piperidinyl}ca rbamate

1.2 Other means of identification

Product number -
Other names [1-(4-amino-6,7-dimethoxy-quinazolin-2-yl)-piperidin-4-ylmethyl]-carbamic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:883106-52-3 SDS

883106-52-3Relevant articles and documents

TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

-

Page/Page column 100, (2012/12/13)

Certain compounds and pharmaceutically acceptable salts are provided herein. Also provided are pharmaceutical compositions comprising at least one compound or pharmaceutically acceptable salt therein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain disease states responsive to the inhibition of transglutaminase TG2 activity are described. These disease states include neurodegenerative disorders such as Huntington's disease. Also described are methods of treatment include administering at least one compound or pharmaceutically acceptable salt thereof as a single active agent or administering at least one compound or pharmaceutically acceptable salt thereof in combination with one or more other therapeutic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 883106-52-3